Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity
Houman Alimoradi,1,* Khaled Greish,2,3,* Anita Barzegar-Fallah,1 Lama Alshaibani,2 Valeria Pittalà4 1Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand; 2College of Medicine and Medical Sciences, Department of Molecular Medicine, and Nanomedicine Unit, P...
Guardado en:
Autores principales: | Alimoradi H, Greish K, Barzegar-Fallah A, Alshaibani L, Pittalà V |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cad656ae37a74358a089c7c18bf9bac0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cytotoxicity, nitric oxide and acetylcholinesterase inhibitory activity of three limonoids isolated from Trichilia welwitschii (Meliaceae)
por: Dzoyem,Jean P., et al.
Publicado: (2015) -
Nitric oxide biology and chemistry.
Publicado: (1997) -
Inducing angiogenesis with the controlled release of nitric oxide from biodegradable and biocompatible copolymeric nanoparticles
por: Yang C, et al.
Publicado: (2018) -
Nitric Oxide Mediation in Hydroxyurea and Nitric Oxide Metabolites’ Inhibition of Erythroid Progenitor Growth
por: Tijana Subotički, et al.
Publicado: (2021) -
Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer
por: Gu Y, et al.
Publicado: (2016)